Mayo Clinic offers new treatment for patients with long-term fecal incontinence

A clinical team on Mayo Clinic's Florida campus is the first to offer four patients with long-term fecal incontinence a new and potentially long-lasting treatment — a small band of interlinked magnetic titanium beads on a titanium string that successfully mimics the function of the anal sphincter.

At this point, Mayo Clinic is the only medical center that has surgically implanted this device, known as the Fenix Continence Restoration System. In December 2015, the system received U.S. Food and Drug Administration approval under a humanitarian device exemption, which requires approval for patient use by a hospital's Institutional Review Board (IRB). The IRB at Mayo Clinic is the first and, as yet, the only center to approve use of the device.

The issue of fecal incontinence, or accidental bowel leakage, is not unusual. It can affect more than 20 percent of women over 45, says Paul Pettit, M.D., a female pelvic medicine and reconstructive surgery specialist at Mayo Clinic. "The condition can be debilitating due to social isolation, depression, loss of self-esteem and self-confidence.

"If a patient does not improve through use of less invasive techniques, our only option has been a colostomy," says Dr. Pettit, who performed the four surgeries. "This device now offers a new option that restores function, and we are happy to be able to offer it."

The operation itself lasts about 45 minutes and requires an overnight hospital stay.

Most patients with fecal incontinence — a syndrome that involves unintentional loss of solid or liquid stool — are women, and often the cause is childbirth, when the muscles and nerves near the anus are damaged, Dr. Pettit says.

When the system is implanted, the string of magnetic titanium beads is placed around the anal canal in the closed position. Increased intra-abdominal pressure opens the beads to allow for passage of stool. The magnets then spontaneously close.

The device works immediately after surgery and does not require any activation by the patient or adjustments by a physician, according to the manufacturer, Torax Medical Inc., in St. Paul, Minnesota.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover two classes of genetic causes for pediatric chordoma